Our one-year survival rates exceed those of other stem cell transplant centers. Based on data from 182 patients who had their first allogeneic transplant (cells from a related or unrelated donor/cord blood) during 2015, 2016, 2017, the one-year survival of these patients is 89.3%, compared to similar patients transplanted at other U.S. centers, where the the rate ranged between 77.9% and 88.2%.